About Genomic Prediction
Genomic Prediction is a company based in North Brunswick (United States) founded in 2017. It operates as a B2B. Genomic Prediction has raised $4.5 million across 1 funding round from investors including Nimble Ventures and PeopleFund. Genomic Prediction operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Auxogyn, Overture Life and Clinical Microbiomics, among others.
- Headquarter North Brunswick, United States
- SectorsHealthcare
- Website genomicprediction.com
- Total Equity Funding$4.5M (USD)
in 1 rounds
- Latest Funding Round$4.5M (USD), Series A
Jan 2019
- InvestorsNimble Ventures
& 1 more
Funding Insights of Genomic Prediction
Genomic Prediction has successfully raised a total of $4.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.5 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.5M
- Total Rounds 1
- Last Round Series A — $4.5M
- First Round $4.5M
(Jan 2019)
- Investors Count 2
All 1 funding rounds of Genomic Prediction with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | $4.5M | Series A | – | Nimble Ventures |
2 investors in total: 2 institutional.
Investors in Genomic Prediction
Genomic Prediction has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Nimble Ventures and PeopleFund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital investments are provided by Nimble Ventures. | – | nimbleventures.ca | Toronto, Canada | |
Seed to growth stage tech-focused VC and PE firm investing in geographies such as the US | – | peoplefund.com | Miami, United States |
Investor details for Genomic Prediction
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genomic Prediction
16 people are tracked at Genomic Prediction (7 in leadership, 4 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Jennifer Eccles | Head of Genetic Counseling & Clinical Content Manager | Leadership |
Leslie Duffy | Head Of Operations | Leadership |
Jia Xu | CTO | Leadership |
Diego Marin | Head Of Global Business Development And Scientific Affairs | Leadership |
Talia Metzgar | Senior Director And Head Of Medical Affairs | Leadership |
Laurent Christian Asker Melchior Tellier | CEO | Leadership |
Lucy Laranjeiro | Director Of Business Operations | Leadership |
Simon Fishel | Scientific Advisor | Board & advisors |
Kathy Miller | Scientific Advisor | Board & advisors |
Serena H. Chen | Scientific Advisor | Board & advisors |
Jamie Metzl | Scientific Advisor | Board & advisors |
Deirdre Leahy | Genetic Counselor | Team |
Elizabeth Carr | Patient Advocate | Team |
Michael P. | Senior Devops Engineer | Team |
Adrienne Faunce | Client Relationship Specialist | Team |
Charlene Alouf | Medical Science Liaison | Team |
Complete people profiles for Genomic Prediction
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Genomic Prediction
2 dated milestones of Genomic Prediction across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Genomic Prediction is founded.
- Funding First funding round of $4.5M.
Competitors of Genomic Prediction
Genomic Prediction operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Auxogyn, Overture Life and Clinical Microbiomics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| auxogyn.com | 2008 | Menlo Park, United States | $78.35M | 384 | Diagnostic technologies for IVF embryo viability assessment are developed. | |
| overture.life | 2017 | Palo Alto, United States | $49.2M | – | Embryology diagnosis devices are developed for medical professionals. | |
| clinical-microbiomics.com | 2016 | Horsholm, Denmark | $9.71M | 35 | Meta-genomics platforms and services for microbiome studies are provided. | |
| bgi.com | 1999 | Shenzhen, China | – | 25 | BGI is engaged in genomics and precision medicine solutions. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. | |
| basecare.cn | 2010 | Suzhou, China | $36.52M | – | NGS-based diagnostic solutions for neonatal screening are developed. | |
| enarabio.com | 2016 | Oxford, United Kingdom | $84.05M | 38 | T-cell interfaces for cancer therapeutics are developed. | |
| 20n.com | 2013 | San Francisco, United States | $2.22M | – | Computational tools are developed to engineer microbes for synthetic biology. |
Detailed competitors of Genomic Prediction
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genomic Prediction
The website of Genomic Prediction (genomicprediction.com) receives about 1.2K visits a month.
- Monthly visits1.2K
Latest news on Genomic Prediction
Complete news archive for Genomic Prediction
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Genomic Prediction
10 companies that operate in the same segment as Genomic Prediction (Clinical Genomics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Panomic profiling technologies are developed for cancer precision medicine. | 1996 | Irving, Texas, United States | USD 1.23 B | – | 1,339 | |
Genomics-based diagnostic tests for cancer are provided. | 2010 | Cambridge, Massachusetts, United States | USD 96.5 M | – | – | |
Digital molecular biology analytics are developed for disease management. | 2012 | Carlsbad, California, United States | USD 95.02 M | – | 46 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Genomic database for clinical research is provided. | 2015 | San Francisco, California, United States | USD 435 M | – | – | |
Genomic sequencing and diagnosis software is provided for healthcare. | 2011 | Menlo Park, California, United States | USD 87.3 M | USD 69.65 M | 229 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genomic Prediction
Genomic Prediction was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Genomic Prediction is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.
Genomic Prediction is a funded company, having raised a total of $4.5M across 1 funding round to date. The company's 1st funding round was a Series A of $4.5M, raised on Jan 2019.
Genomic Prediction operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and ivf testing. Offers genomics tests to predict health outcomes for IVF procedures. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Genomic Prediction's top competitors include Novogene Corporation, BGI and Overture Life.
Genomic Prediction has 2 investors. Key investors include Nimble Ventures, and PeopleFund.